Three Fold Risk of Atrial Fibrillation in Ibrutinib Treated CLL Patients without Increased Risk of Stroke: A SEER-Medicare Database Analysis

Autor: Diamond, Akiva, Bensken, Wyatt P., Dong, Weichuan, Markt, Sarah C., Koroukian, Siran M., Caimi, Paolo
Zdroj: Blood; November 2020, Vol. 136 Issue: Supplement 1 p18-19, 2p
Abstrakt: Koroukian: Cleveland Clinic Foundation: Research Funding; Celgene: Research Funding. Caimi:Celgene Corp: Other: Incyte Corporation - Ownership - Pharmacyclics, Inc. - Ownership - Celgene Corp. - Other, Speakers Bureau; Genentech: Research Funding; ADC Therapeutics: Research Funding.
Databáze: Supplemental Index